The same goes for anyone with a peptide allergy
The SURMOUNT-4 discontinuation data The SURMOUNT-4 trial specifically studied what happens when you stop tirzepatide after successful weight loss
Histochem Cell Biol 160(4):341347
Wegrowski Y, Maquart FX, Borel JP
Purity: 99% HPLC | For research use only Categories: All Peptides, Weight Loss Tags: Anti-Diabetic Peptide, Appetite Suppression, C225H348N48O68, CAS 2023788-19-2, Dual Incretin Peptide, Fat Reduction, GIP Receptor Agonist, GLP-1, GLP-1 Analog, GLP-1/GIP Agonist, Glucose Control, Incretin Research, Insulin Sensitivity, Metabolic Disease Model, Metabolic Health, Obesity Research, Tirzepatide, Tirzepatide 10mg, Tirzepatide Research, Type 2 Diabetes Research, Weight Loss
Djukic et al., 2022)